CONTENTS

Issue 98 | September 2020

In association with

timeline

A look inside the longest running collection of bacteria type cultures 

Drug targets

The gut-brain axis has become a promising target for gastrointestinal disorders

testing

Why is horseshoe crab blood so difficult to replace in clinical trials?

insight

Puberty blockers are a controversial option for transgender children

recruitment

The Covid-19 pandemic could help bring more young talent into the pharma sector

Q&A: packaging 

Packaging company Honeywell explains what's next for packaging in pharma

Drug development

Examining the current state of drug development for rare diseases

Regulation

Can AI legally own the rights to drug discovery patents?

Insight

How can pharma companies become more agile and responsive to market changes?

Comment

Harnessing compliance as a lever for doing better business and enhancing market trust

02/23/2024 20:48:13
  • Home | Pause for thought
  • In this issue
  • NSF
  • Contents
  • Datwyler Company Insight
  • Datwyler
  • News
  • Baxter
  • Covid-19 executive briefing by GlobalData
  • ELPRO Monitoring Solutions
  • Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success
  • Abiomed’s Impella receives FDA Emergency Use Authorization during Covid-19
  • Fargo
  • Disruptions to global oncology trials have fallen to a three-month low
  • Mimotopes
  • AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine cli
  • Biotech IPO valuation relies on data to enter capital markets during Covid-19 pa
  • Nelson Labs
  • The pharma industry briefing
  • Pfeiffer Vacuum
  • A century of cultures: celebrating the world’s oldest lab culture collection
  • Skyepharma
  • Gut feeling: exploring the therapeutic potential of the gut-brain axis
  • Optel
  • Crabby concoctions: why pharma’s thirst for crustacean blood is up for debate
  • Air France
  • Debunking myths about puberty blockers for transgender children
  • Micronova
  • Hiring from home: pharma recruitment in the age of Covid-19
  • Nipro Pharmapackaging
  • Q&A: breaking new ground in pharma packaging with Honeywell
  • Wipotec
  • Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
  • VEGA Company Insight
  • VEGA Australia
  • Modernising pharma patents: can AI be an inventor?
  • ILC Dover
  • Boosting agility to accelerate project timescales
  • Scandinavian Health
  • Doing the right thing: the enhanced case for compliance
  • Deals in brief powered by GlobalData
  • The key list powered by GlobalData
  • Global markets and indices powered by GlobalData
  • Macro-economic indicators (1 of 2) powered by GlobalData
  • Macro-economic indicators (2 of 2) powered by GlobalData
  • Events
  • Next issue
08/24/2020 00:00:00